Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Clinical Trial Evidence and Findings in Female Participants Phase 2 trial data (Jastreboff et al., NEJM, 2023) showed dose-dependent weight reduction and metabolic improvements, but sex-disaggregated results were not published, so female-specific efficacy cannot yet be confirmed
When used under medical supervision, tirzepatide not only supports weight lossit can also help reduce inflammation, improve metabolic health, and lower your risk of weight-related conditions like high blood pressure, insulin resistance, and cardiovascular disease
These health issues often develop over time, making early intervention critical
We are a professional peptide manufacturer with advanced equipment, large-scale laboratories, and strict quality control ensuring consistent and reliable production How is the product shipped
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: Post-hoc analysis of an open-label, randomised, phase 3 trial
A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis concluded that carnitine supplementation:[3] achieved a modest reduction in body weight , improving Body Mass Index (BMI) and reducing adipose tissue
